These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 1893319

  • 1. Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.
    Scheifele DW, Meekison W, Grace M, Barreto L, Carter AO, Mitchell L, Farley J.
    CMAJ; 1991 Sep 15; 145(6):641-7. PubMed ID: 1893319
    [Abstract] [Full Text] [Related]

  • 2. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine.
    Scheifele DW, Bjornson G, Halperin SH, Mitchell L, Boraston S.
    CMAJ; 1994 Jan 01; 150(1):29-35. PubMed ID: 8275406
    [Abstract] [Full Text] [Related]

  • 3. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B.
    CMAJ; 1993 Oct 15; 149(8):1105-12. PubMed ID: 8221449
    [Abstract] [Full Text] [Related]

  • 4. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM, Predy G, Guasparini R, Law B, Diaz-Mitoma F, Whitstitt P, Tapiero B, Dionne M, Tomovici A, Mills E, Halperin SA.
    Vaccine; 2007 Jan 22; 25(6):1121-5. PubMed ID: 17045366
    [Abstract] [Full Text] [Related]

  • 5. Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial.
    Jackson LA, Dunstan M, Starkovich P, Dunn J, Yu O, Nelson JC, Rees T, Zavitkovsky A.
    Pediatrics; 2006 Mar 22; 117(3):620-5. PubMed ID: 16510639
    [Abstract] [Full Text] [Related]

  • 6. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC, Sharma SB, Kumar A, Sokhey J.
    J Commun Dis; 1998 Mar 22; 30(1):23-8. PubMed ID: 9842161
    [Abstract] [Full Text] [Related]

  • 7. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M, Komiya T, Takahashi M, Yasuda Y, Taniguchi T, Zhao Y, Matano K, Matsui H, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2004 Aug 13; 22(23-24):3061-8. PubMed ID: 15297056
    [Abstract] [Full Text] [Related]

  • 8. Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program.
    Okada K, Ueda K, Morokuma K, Kino Y, Tokugawa K, Nishima S.
    Jpn J Infect Dis; 2004 Apr 13; 57(2):67-71. PubMed ID: 15118214
    [Abstract] [Full Text] [Related]

  • 9. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.
    Vaccine; 2006 Jul 07; 24(27-28):5627-36. PubMed ID: 16740348
    [Abstract] [Full Text] [Related]

  • 10. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.
    J Pediatr; 2006 Nov 07; 149(5):603-610. PubMed ID: 17095328
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA, King J, Law B, Mills E, Willems P.
    Clin Infect Dis; 1999 May 07; 28(5):995-1001. PubMed ID: 10452624
    [Abstract] [Full Text] [Related]

  • 12. Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid component.
    Jackson LA, Falls S, Yu O, George J, Pietrobon PJ, Rubanowice D, Froeschle J.
    J Infect Dis; 2001 Jun 01; 183(11):1698-700. PubMed ID: 11343223
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.
    Pediatrics; 2006 Sep 01; 118(3):e602-9. PubMed ID: 16950952
    [Abstract] [Full Text] [Related]

  • 14. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
    Hong HA, Ke NT, Nhon TN, Thinh ND, van der Gun JW, Hendriks JT, Kreeftenberg JG.
    Bull World Health Organ; 1996 Sep 01; 74(3):275-82. PubMed ID: 8789926
    [Abstract] [Full Text] [Related]

  • 15. Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese infants at 2, 4, and 6 months of age.
    Rothstein EP, Kamiya H, Nii R, Matsuda T, Bernstein HH, Long SS, Hosbach PH, Meschievitz CK.
    Pediatrics; 1996 Feb 01; 97(2):236-42. PubMed ID: 8584384
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
    Halperin SA, McDonald J, Samson L, Danzig L, Santos G, Izu A, Smith B, MacDonald N.
    Clin Invest Med; 2002 Dec 01; 25(6):243-51. PubMed ID: 12516995
    [Abstract] [Full Text] [Related]

  • 17. Reactogenicity of fluid compared with adsorbed diphtheria-pertussis-tetanus vaccine.
    Mathias RG.
    Can Med Assoc J; 1984 Jun 15; 130(12):1561-5. PubMed ID: 6610469
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.
    Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216
    [Abstract] [Full Text] [Related]

  • 19. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD.
    Pediatr Infect Dis J; 2006 Mar 10; 25(3):195-200. PubMed ID: 16511379
    [Abstract] [Full Text] [Related]

  • 20. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J, Trollfors B, Knutsson N.
    Dev Biol Stand; 1997 Mar 10; 89():109-12. PubMed ID: 9272340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.